Viewing StudyNCT00143975



Ignite Creation Date: 2024-05-05 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00143975
Status: COMPLETED
Last Update Posted: 2010-08-12
First Post: 2005-08-31

Brief Title: Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML GO-A-HAM
Sponsor: University of Ulm
Organization: University of Ulm

Conditions & Keywords Data

Conditions:
Name
Leukemia Myeloid Acute
Keywords:
Name View
refractory disease View
Acute myeloid leukemia View
gemtuzumab ozogamicin View